Home » Stocks » AZRX

AzurRx BioPharma, Inc. (AZRX)

Stock Price: $0.794 USD 0.020 (2.56%)
Updated November 30, 4:00 PM EST - Market closed
After-hours: $0.800 +0.006 (0.72%) Nov 30, 5:56 PM

Stock Price Chart

Key Info

Market Cap 24.16M
Revenue (ttm) n/a
Net Income (ttm) -16.55M
Shares Out 30.41M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $0.794
Previous Close $0.775
Change ($) 0.020
Change (%) 2.56%
Day's Open 0.810
Day's Range 0.770 - 0.818
Day's Volume 289,541
52-Week Range 0.500 - 1.720

More Stats

Market Cap 24.16M
Enterprise Value 12.74M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 30.41M
Float n/a
EPS (basic) -0.86
EPS (diluted) -0.90
FCF / Share -0.30
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 62,821
Short Ratio 0.52
Short % of Float n/a
Beta 1.83
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.67
Revenue n/a
Operating Income -10.16M
Net Income -16.55M
Free Cash Flow -8.57M
Net Cash 11.41M
Net Cash / Share 0.38
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -48.55%
ROE -191.73%
ROIC 1,185.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.67*
(487.94% upside)
Low
3.00
Current: $0.794
High
7.00
Target: 4.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-14.74-13.22-10.08-6.63-4.73-2.33
Net Income-15.18-13.53-11.10-14.59-5.93-2.37
Shares Outstanding22.4315.4410.636.503.633.54
Earnings Per Share-0.68-0.88-1.04-2.24-1.63-0.67
Operating Cash Flow-14.03-10.87-7.18-4.53-4.17-1.01
Capital Expenditures-0.02-0.06-0.03-0.01-0.02-0.19
Free Cash Flow-14.06-10.92-7.22-4.55-4.19-1.20
Cash & Equivalents0.221.160.601.810.660.24
Total Debt1.520.260.420.166.581.05
Net Cash / Debt-1.300.900.191.65-5.91-0.81
Assets8.907.475.486.756.696.58
Liabilities4.293.003.823.5410.323.93
Book Value4.624.471.663.21-3.632.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AzurRx BioPharma, Inc.
Country United States
Employees 10
CEO James E. Sapirstein

Stock Information

Ticker Symbol AZRX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AZRX
IPO Date October 11, 2016

Description

AzurRx BioPharma, a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. The company's therapeutic products are administered to patients as oral non-systemic biologics. Its lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency for cystic fibrosis and chronic pancreatitis patients. The company was incorporated in 2014 and is headquartered in Delray Beach, Florida.